Clinical Research
Filter News
Found 111,163 articles
-
Serum neurofilament is a discriminative biomarker between frontotemporal dementia and psychiatric disorders
10/15/2019
Early symptoms of frontotemporal dementia are often confused with symptoms occurring in psychiatric disorders.
-
Ortho Clinical Diagnostics Expands Drugs of Abuse and Therapeutic Drug Assay Menus in Collaboration With Thermo Fisher Scientific
10/15/2019
New MicroTip Partnership Assays (MPAs) Help Detect the Use of Fentanyl and Tricyclic Antidepressants (TCA)
-
The Challenge of Cultured Meat
10/14/2019
Aleph Farms announced last week they 3D printed a small piece of muscle tissue on the International Space Station. The success of this miniature steak highlights the key advantage of cultivated meat: you can make it anywhere. -
A new study shows that a PARP inhibitor combined with a DNA methyltransferase inhibitor may be a new way of treating some lung cancers.
-
Employees’ Perception vs. Employers’ Reality! New Research Shows the Top 3 Areas of Opportunity
10/14/2019
What makes an organization a desirable employer? Do they need to be a large company with a recognizable name? Should the organization pay their employees more than others? -
Researchers found that an injectable hormone called tesamorelin decreases liver fat and prevented liver fibrosis in this patient population.
-
Survey Reveals Costly Disconnect Between Physicians and Hospitals About Retirement
10/14/2019
New Jackson Physician Search Study Shows Doctors Consider Less Notice on Retirement Necessary, Introducing Potential Repercussions for Hospital Finances
-
Global Cell Sorting Market 2019-2023 | Evolving Opportunities with Becton, Dickinson and Co., and Bio-Rad Laboratories Inc. | Technavio
10/14/2019
Technavio has been monitoring the global cell sorting market since 2018 and the market is poised to grow by USD 83.63 million during 2019-2023, progressing at a CAGR of around 7% during the forecast period
-
Exicure to Present Clinical Results from XCUR17 at the 15th Annual Meeting of the Oligonucleotide Therapeutics Society
10/14/2019
Exicure, Inc., a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid constructs, announced that its CEO, David Giljohann, PhD, will present clinical data from the company’s Phase 1 study of its drug candidate XCUR17 in psoriasis.
-
Susan G. Komen® Urges Commitment to Conquer Metastatic Breast Cancers
10/14/2019
Komen vows to drive breakthroughs for the most-deadly breast cancers and educate those who believe breast cancers are easily treated or always curable
-
RMA Unveils Landmark Research on IVF Safety, Success at ASRM
10/14/2019
Historic studies reaffirm the accuracy of embryo genetic testing; show women with three euploid embryos have a 95% chance of pregnancy; and reveal IVF babies have equaled their naturally-conceived counterparts in birth weights for the first time
-
REMINDER - Tesamorelin Study Results on NAFLD Published in Lancet HIV
10/14/2019
NAFLD is a substantial cause of liver-related morbidity in people living with HIV and is a precursor of Non-alcoholic steatohepatitis
-
ReNeuron Presents Positive Clinical Data at the American Academy of Ophthalmology Annual Meeting
10/14/2019
Study investigator presents positive efficacy data in ongoing retinal disease clinical trial
-
Allen Institute Debuts New Window Into Brain Cell Communication
10/14/2019
Coupled with new research on brain cell types and connections, these data allow the scientific community to explore questions about brain diseases and psychiatric disorders
-
Femtogenix Presents Efficacy and Toxicity Data on Antibody Drug Conjugates Containing New Generation of DNA-binding Therapeutic Payloads
10/14/2019
Studies demonstrate superior efficacy and cytotoxicity of Femtogenix’s sequence-selective DNA-interactive payload molecules toward tumour cells
-
Matinas BioPharma Initiates EnACT Study of MAT2203 (Oral Amphotericin B) for the Treatment of Fungal Cryptococcal Meningitis
10/14/2019
Matinas BioPharma Holdings, Inc. announced that it has initiated its Phase 2 EnACT clinical study, which will explore the use of MAT2203 for both induction and maintenance therapy in HIV-patients with cryptococcal meningitis, a life-threatening fungal infection most commonly observed in immunocompromised individuals.
-
Smokers have more blood clots in the lung, leading to higher hospital readmission rates
10/14/2019
Patients with lung blood clots who smoke are more likely to be readmitted for lung blood clots than nonsmokers, according to Kam Sing Ho, MD, from Mount Sinai St. Luke's and Mount Sinai West in New York City, who will present the study findings at the CHEST Annual Meeting 2019 in New Orleans.
-
Vaping is not a safe substitute for smoking and can damage the lungs--a case study of granulomatosis resulting from vaping
10/14/2019
Vaping is not a low-risk substitute for smoking cigarettes, according to researcher Charlie Lin, MD, who authored a case study of a 34-year-old former smoker diagnosed with granulomatosis attributed to two months of electronic cigarette use.
-
Phase III PEMPHIX Study Shows Genentech’s Rituxan (rituximab) Superior to Mycophenolate Mofetil in Patients With Pemphigus Vulgaris
10/14/2019
40% of patients with pemphigus vulgaris (PV) achieved sustained complete remission, without the use of steroids for 16 weeks or more, when treated with Rituxan compared to 9.5% of patients on mycophenolate mofetil
-
Aclidinium is safe and reduces COPD flare-ups, regardless of recent exacerbations
10/14/2019
Dr. Wise noted that there are a few implicit issues surrounding the use of AB, "First, there has been some controversy over the cardiovascular safety of aclidinium, which this study shows not to be a problem.